Evaluation of sequential testing strategies using non-amplified and amplified methods for detection of Chlamydia trachomatis in endocervical and urine specimens from women

Diagnostic Microbiology and Infectious Disease

Volumn 42, Issue 1, 2002, Pages 43-51

  Semeniuk, Heather ^a   Zentner, Ali ^a   Read, Ron ^a   Church, Deirdre ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOMATION; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; GENITAL TRACT INFECTION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; URINALYSIS; UTERINE CERVICITIS; UTERINE ENDOCERVIX;

ADOLESCENT; ADULT; AGED; CANADA; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCIBILITY OF RESULTS;

EID: 0036159557     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00315-7     Document Type: Article

References (26)

1. Current methods of laboratory diagnosis of Chlamydia trachomatis infection
2. "But Doctor, I'm Celibate!" The potential for, sources and implications of false-positive (and negative) results of tests for Chlamydia trachomatis
3. Recommendations for the prevention and management of Chlamydia trachomatis infections
4. Genital chlamydial infections: Epidemiology and reproductive sequelae
5. A 1-year evaluation of Syva Microtrak Chlamydia enzyme immunoassay with selective confirmation by direct fluorescent-antibody assay in a high-volume laboratory
6. An algorithm to detect Chlamydia trachomatis by polymerase chain reaction on specimens extracted for enzyme immunoassay
7. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia trachomatis assay (AMP CT) in urine specimens from men and women and endocervical specimens from women
8. Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of Chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection
9. Performance of the Gen-Probe AMPLIFIED Chlamydia trachomatis assay in detecting Chlamydia trachomatis in endocervical and urine specimens from women and urethral and urine specimens from men attending sexually transmitted disease and family planning clinics
10. Diagnostic tests
11. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management
12. Direct fluorescent-antibody confirmation of chlamydial antigen below the detection threshold of the Chlamydiazyme enzyme-linked immunosorbent assay
13. Comparison of the PACE 2 assay, two amplification assays and clearview EIA for detection of Chlamydia trachomatis in female endocervical and urine specimens
14. Role of confirmatory PCRs in determining performance of Chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection
15. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: Performance of the LCx and COBAS AMPLICOR tests with urine specimens
16. Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: Cost-saving strategy for epidemiological studies and screening programs
17. Head to head evaluation of five different nonculture Chlamydia tests relative to a quality-assured culture standard
18. Cervical neoplasia and other STD-related genital and anal neoplasias
19. A review of the microbiology, immunology, and clinical manifestations of Chlamydia trachomatis infections
20. Sexually transmitted diseases: Impact of molecular laboratory diagnostic methods on disease control and prevention
21. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women
22. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing
23. Epidemiological synergy: Interrelationships between HIV infection and other STDs
24. Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections
25. Comparison of polymerase chain reaction, monoclonal antibody based enzyme immunoassay, and cell culture for detection of Chlamydia trachomatis in genital specimens
26. Comparative evaluation of Chlamydiazyme, PACE 2, and AMP-CT assays for detection of Chlamydia trachomatis in endocervical specimens